{"CONCEPT_ID":[19080226],"CDM_TABLE_NAME":["DRUG_ERA"],"CONCEPT_NAME":["milnacipran"],"NUM_PERSONS":[1],"PERCENT_PERSONS":["0.0008"],"RECORDS_PER_PERSON":[" 1.0"],"AGE_AT_FIRST_EXPOSURE":[{"CATEGORY":"FEMALE","MIN_VALUE":42,"P10_VALUE":42,"P25_VALUE":42,"MEDIAN_VALUE":42,"P75_VALUE":42,"P90_VALUE":42,"MAX_VALUE":42}],"PREVALENCE_BY_GENDER_AGE_YEAR":[{"TRELLIS_NAME":"40-49","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":2011,"Y_PREVALENCE_1000PP":12.6582}],"PREVALENCE_BY_MONTH":[{"X_CALENDAR_MONTH":201112,"Y_PREVALENCE_1000PP":1.0277}],"LENGTH_OF_ERA":[{"CATEGORY":"Length of Era","MIN_VALUE":30,"P10_VALUE":30,"P25_VALUE":30,"MEDIAN_VALUE":30,"P75_VALUE":30,"P90_VALUE":30,"MAX_VALUE":30}]}
